Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled T
![Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6307fdea-1907-4477-9baa-fca7893c24e4/pedi.v22.8.cover.jpg)
Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers - Kostopoulou - 2021 - Pediatric Diabetes - Wiley Online Library
![A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnutd.2017.16/MediaObjects/41387_2017_Article_BFnutd201716_Fig1_HTML.jpg)
A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes | Nutrition & Diabetes
Delayed presentation of seropositivity in pre-existent coeliac disease in patients with Type 1 diabetes mellitus: a possible co-
![Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances](https://www.science.org/cms/10.1126/sciadv.aaw4357/asset/e11ddf64-177d-4f83-b2a3-14139cdd961f/assets/graphic/aaw4357-f5.jpeg)
Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances
![Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d549c750-9e95-48c8-88a4-b33a3c58f07e/gr1_lrg.gif)
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology
![Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances](https://www.science.org/cms/10.1126/sciadv.aaw4357/asset/91b98181-b3e2-43bc-9fb2-dd7c4d2f1f2b/assets/graphic/aaw4357-f4.jpeg)
Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs | Science Advances
CHAPTER ONE 1.0 BACKGROUND Diabetes mellitus is defined as a “metabolic disorder caused by different factors characterized by
![PDF) Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers PDF) Oxidized lipid‐associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic/prognostic clinical markers](https://i1.rgstatic.net/publication/355180069_Oxidized_lipid-associated_protein_damage_in_children_and_adolescents_with_type_1_diabetes_mellitus_New_diagnosticprognostic_clinical_markers/links/616c393d25467d2f00487395/largepreview.png)